2m 2m 2m 2m 2m 2m 2m
CV Sciences (CVSI)
OTC
$0.02+$0.001 (+5.90%)
Price as of Jun 24, 2026- $4.5MMarket Cap
- -43.44%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CV Sciences (CVSI)
$0.02+$0.001 (+5.90%)
CVSI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.02 | ||
Change | +$0.001 (+5.90%) | ||
Open | $0.02 | ||
High | $0.02 | ||
Low | $0.02 | ||
Previous Close | $0.02 | ||
Volume | 336,634 | ||
30-Day Average Volume | 679,759 | ||
1-Week Change | 22.22% | ||
1-Month Change | -27.82% | ||
1-Year Change | -43.44% | ||
3-Year Change | -47.62% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 204.0M | ||
Total Assets | $6.7M | ||
Market Cap | $4.5M | ||
Enterprise Value | $4.3M | ||
Period: QTR TTM FY | |||
Revenue | $3.2M | ||
Net Income | -$643,000.00 | ||
Free Cash Flow | $98,000.00 | ||
EBIT | -$643,000.00 | ||
EBITDA | -$620,000.00 | ||
Net Working Capital | -$185,000.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 3 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 46 | ||
Price/Operating Cash Flow | 44 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue